The Russian news agency TASS in January reported that the nasal vaccine will be in civil circulation and available for Russians within 3-4 months, quoting the director of the Gamaleya Centre, Alexander Gintsburg.
Central Drugs Laboratory clears 2 more vaccines, panel awaits approval for kids - Additionally, the laboratory has approved 1.85 crore doses of Johnson & Johnson’s single-shot Covid-19 vaccine manufactured by Biological E in India.
India Today has accessed the order by the Central Drugs Standard Control Organisation approving the extension of the shelf life of Covaxin from six months to 12 months.